Kristi Kung focuses on the representation of healthcare clients in a range of regulatory, compliance and transactional matters. She is a member of the firm's Healthcare Industry team in the Northern Virginia and Washington, DC offices.

Kristi advises healthcare providers, emerging health IT companies, vendors and investors in the digital health industry on regulatory and strategic matters critical to her client's telehealth and other health technology products, platforms and services. She has worked with digital health startups, IT vendors and health systems to develop and implement telehealth networks throughout the United States and internationally.

Kristi also represents healthcare clients in a range of regulatory, compliance and transactional matters, including fraud and abuse, health information privacy and security, billing and reimbursement, and licensing and accreditation of healthcare providers and suppliers. She advises on the health regulatory requirements and risks related to mergers and acquisitions, insolvency and restructuring matters, private equity investment and healthcare lending transactions and has served as an independent compliance reviewer for entities under Corporate Integrity Agreements.

Her portfolio also includes the representation of hospitals, pharmacies and other covered entities with respect to 340B Drug Discount Pricing Program compliance, audits and appeals.